Myriad Pharmaceuticals Announces Presentations at 2010 ASCO Annual Meeting SALT LAKE CITY, May 20, 2010 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals Inc. (Nasdaq:MYRX) today announced that it will be reporting data on its lead oncology candidate, Azixa™ (MPC-6827),...

Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company Company Will Advance Three Clinical Development Programs in Oncology and Infectious Disease Conference Call Scheduled for 10:00 AM EDT On July 1,...

Myriad Pharmaceuticals, Inc. to Host Initial Public Conference Call On July 1, 2009 SALT LAKE CITY, June 29, 2009 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals, Inc. (Nasdaq:MYRXV) today announced that it will hold a live webcast on Wednesday, July 1, 2009 at 10:00 AM EDT. Adrian...